Purchase Order 75D30124P00086
Award Date
10/1/24
Potential Completion Date
11/8/29
Potential Value
$31K
Federal Agency
CDC Pittsburgh
Awardee
Vela Diagnostics USA Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fairfield, NJ 07004, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to provide maintenance services for the Sentosa SQ HIV genotyping systems. The contract has a potential value of $100,000.00 and a period of performance ending on September 29, 2027. Vela Diagnostics USA Inc. is a global provider of integrated molecular diagnostic solutions that has previously supported federal agencies such as the Department of Veterans...
Vela Diagnostics USA Inc. was awarded a $185,261 firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) to provide VELA Diagnostics equipment. The CDC, a component of the Department of Health and Human Services, works to protect public health and safety through the control and prevention of disease, injury, and disability. This award was made directly without a set-aside designation and calls for the equipment to be delivered to a location in Fairfield, New...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Vela Diagnostics USA Inc., a for-profit organization, to provide viral next-generation sequencing (NGS) testing for genotyping and resistance of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) at a cost of $148,104.85. The contract, which was not set aside, has a completion date of September 30, 2022. Vela Diagnostics USA Inc. has previously provided federal agencies,...
The Centers for Disease Control and Prevention (CDC) awarded a $95,931 firm-fixed-price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a MiSeq next-generation DNA sequencing system. This sole-source award is intended to support the CDC's public health need for enhanced monitoring of HIV drug resistance in countries receiving PEPFAR (President's Emergency Plan for AIDS Relief) funding. Illumina was selected as the sole source due to its...
This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Vela Diagnostics USA Inc. for the delivery of SARS-CoV-2 test reagents. The contract, valued at $86,922.21, has an ultimate completion date of October 8, 2021. Vela Diagnostics USA Inc. is a for-profit organization that has previously provided equipment rental, reagents, consumables, and research and development to support COVID-19 testing, HIV genotyping, and next-generation sequencing systems for various...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Vela Diagnostics USA Inc., a global provider of integrated molecular diagnostic solutions. The contract, valued at $1,439,264.40, is for the rental of a VELA SQ SENTOSA Next Generation Sequencing (NGS) System. This equipment and associated services will support critical public health initiatives through the provision of leading diagnostic technologies. The contract does not have a set-aside designation....
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
The Centers for Disease Control and Prevention (CDC) awarded a sole-source, firm-fixed-price purchase order to Roche Diagnostics Corporation to provide biomedical reagents, testing supplies, and commodities required to conduct HIV molecular laboratory testing. The $25,725.24 contract has an ultimate completion date of October 17, 2029. The requirement is not set aside, as Roche Diagnostics is identified as the only vendor capable of providing the proprietary reagents and supplies compatible with...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Life Technologies Corporation, a for-profit organization, for $105,600.00 to provide HIV-1 Genotyping Kits including Amplification Modules and Cycle Sequencing Modules. This sole source award, with no set-aside, was made on September 6, 2018, with a completion date of August 31, 2019. Life Technologies Corporation is a provider of tools and technologies for...